ArticleUpdates in surgery2026
The impact of liver-first approach on primary cancer surgery in patients with syncronous colorectal liver metastases.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver first approach is one of the possible strategies for synchronous CRLM. Less attention is generally reserved to colorectal resection after hepatic surgery. Aim of the study is to investigate the influence of liver resection on primary tumor surgery. In the present monocentric cohort study, patients operated onlaparoscopic CR resection after open or laparoscopic liver surgery are compared (propensity score matching analysis 1:3) with laparoscopically operated non metastatic CR patients in period 2015-2023. Primary endpoint: 30 day morbidity; secondary endpoints: conversion, reintervention and 90 days mortality rate, surgery duration. Forty liver-first and 642 control patients are matched; 40 and 120 patients respectively are compared after matching. Morbidity rate 32.5% and 37.5% (p = 0.568); CCI 100 >20.9 4/40 and 21/120 (p = 0.257); conversion rate 7.5% and 10% (p = 0.638); reintervention 3/40 and 13/120 (p = 0.761); mortality 0/40 and 1/120; surgery duration 288 and 279 min (p = 0.650). No difference in hospital stay (6.5 and 7 days in liver first and control group respectively). Liver-first approach does not worsten intraoperative and post-operative short term outcomes of primary tumor resection.
Indexed as
Identifiers
42332225What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.